Literature DB >> 21862960

Optimizing cancer care: is the future bright?

P Zahedi, R De Souza, M Piquette-Miller.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21862960     DOI： 10.1038/clpt.2011.167

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  The value proposition of molecular medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

Review 2.  GUCY2C molecular staging personalizes colorectal cancer patient management.

Authors:  Jian P Gong; Stephanie Schulz; Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

3.  Nuclear mapping of nanodrug delivery systems in dynamic cellular environments.

Authors:  Ashwinkumar A Bhirde; Ankur Kapoor; Gang Liu; Ramiro Iglesias-Bartolome; Albert Jin; Guofeng Zhang; Ruijun Xing; Seulki Lee; Richard D Leapman; J Silvio Gutkind; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2012-05-02       Impact factor: 15.881

4.  Systems approaches evolve clinical pharmacology.

Authors:  S A Waldman; P H van der Graaf; A Terzic
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.